HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome : interdisciplinary diagnosis and therapy].

AbstractBACKGROUND:
The main symptom of chronic progressive external ophthalmoplegia (CPEO) and Kearns-Sayre syndrome (KSS) are upper eyelid ptosis and a slowly progressive weakness of the extraocular muscles. Mitochondrial disorders are much more frequent than previously assumed. Because of great phenotypic variability, early diagnosis may prove to be difficult.
MATERIAL AND METHODS:
Retrospective analysis of 30 patients with CPEO or KSS with regard to ophthalmological and neurological findings as well as molecular genetic background.
RESULTS:
Twenty-seven patients presented with upper eyelid ptosis as the first clinical symptom. In 11 of these patients, ptosis was either unilateral or asymmetric. External ophthalmoplegia was present in only three patients initially; however, it developed in 27 patients in the later course of the disease. Diplopia was found to be more frequent than previously assumed. Twenty-six patients showed characteristic histological hallmarks in skeletal muscle biopsy. In 22 patients, molecular genetic testing revealed mitochondrial DNA mutations.
CONCLUSIONS:
Mitochondrial disorders should be included in the early differential diagnosis of patients with etiologically unclear acquired isolated unilateral or bilateral ptosis, atypical eye movement disorders, or diplopia. A correct diagnosis is mandatory for qualified counseling and the management of potentially life-threatening complications, such as cardiac involvement.
AuthorsB Wabbels, N Ali, W S Kunz, P Roggenkämper, C Kornblum
JournalDer Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft (Ophthalmologe) Vol. 105 Issue 6 Pg. 550-6 (Jun 2008) ISSN: 0941-293X [Print] Germany
Vernacular TitleChronisch-progressive externe Ophthalmoplegie und Kearns-Sayre-Syndrom : Interdisziplinäre Diagnostik und Therapie.
PMID18373100 (Publication Type: English Abstract, Journal Article)
Chemical References
  • DNA, Mitochondrial
  • Ubiquinone
Topics
  • Adolescent
  • Adult
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Blepharoptosis (etiology)
  • Child
  • Chromosome Deletion
  • Combined Modality Therapy
  • DNA, Mitochondrial (genetics)
  • Female
  • Gene Rearrangement (genetics)
  • Hearing Aids
  • Humans
  • Kearns-Sayre Syndrome (diagnosis, genetics, therapy)
  • Male
  • Middle Aged
  • Neurologic Examination
  • Ophthalmoplegia, Chronic Progressive External (diagnosis, genetics, therapy)
  • Pacemaker, Artificial
  • Patient Care Team
  • Point Mutation (genetics)
  • Polymorphism, Restriction Fragment Length (genetics)
  • Retrospective Studies
  • Ubiquinone (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: